ConductScience.org, home

Paper772175

Bromocriptine treatment in Parkinson's disease.

Parkes JD and 6 others. J Neurol Neurosurg Psychiatry, 1976. Cited by 89 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bromocriptine treatment in Parkinson's disease. Papers, record 772175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/772175

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bromocriptine treatment in Parkinson's disease.
PubMed
Journal
J Neurol Neurosurg Psychiatry
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
3.24
iCite
Revised in PubMed
2019-05-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parkes JDJ D
2Marsden CDC D
3Donaldson II
4Galea-Debono AA
5Walters JJ
6Kennedy GG
7Asselman PP

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErgolinesMajor topic
Parkinson DiseaseMajor topic
Aged
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Evaluation
Female
Growth Hormone
Humans
Male
Middle Aged

Source PubMed

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,213,659A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.Nature1964https://conductscience.org/library/papers/14213659PubMed
24,563,448Injected apomorphine and orally administered levodopa in Parkinsonism.Arch Neurol1972https://conductscience.org/library/papers/4563448PubMed
34,425,916Bromocriptine in Parkinsonism.Br Med J1974https://conductscience.org/library/papers/4425916PubMed
44,402,038Evidence for a new type of dopamine receptor stimulating agent.J Pharm Pharmacol1971https://conductscience.org/library/papers/4402038PubMed
5166,332Studies on the antiparkinsonism efficacy of lergotrile.Neurology1975https://conductscience.org/library/papers/166332PubMed
64,146,398Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.J Pharm Pharmacol1973https://conductscience.org/library/papers/4146398PubMed
74,371,345Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.J Clin Endocrinol Metab1974https://conductscience.org/library/papers/4371345PubMed
84,383,150Evidence for dopamine receptor stimulation by apomorphine.J Pharm Pharmacol1967https://conductscience.org/library/papers/4383150PubMed
94,691,682Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase.J Neurol Neurosurg Psychiatry1973https://conductscience.org/library/papers/4691682PubMed
104,672,297The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).J Clin Endocrinol Metab1972https://conductscience.org/library/papers/4672297PubMed
114,901,383Similarities between neurologic effects of L-dopa and of apomorphine.N Engl J Med1970https://conductscience.org/library/papers/4901383PubMed
121,112,876Apomorphine: effect on growth hormone.J Clin Endocrinol Metab1975https://conductscience.org/library/papers/1112876PubMed
131,117,050Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine.J Clin Endocrinol Metab1975https://conductscience.org/library/papers/1117050PubMed

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
41,819,290Artificial intelligence and multiomics integration for Parkinson's disease drug development.Mol Cells2026https://conductscience.org/library/papers/41819290PubMed
41,009,387Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers.Int J Mol Sci2025https://conductscience.org/library/papers/41009387PubMed
39,718,740Bromocriptine Versus Levodopa and other treatments in Parkinson's Disease: an updated Meta-analysis Involving more than 4000 patients across 12 randomized clinical trials.Acta Neurol Belg2025https://conductscience.org/library/papers/39718740PubMed
38,225,264Parkinson disease psychosis: from phenomenology to neurobiological mechanisms.Nat Rev Neurol2024https://conductscience.org/library/papers/38225264PubMed
36,932,180Psychedelics: preclinical insights provide directions for future research.Neuropsychopharmacology2024https://conductscience.org/library/papers/36932180PubMed
35,711,802Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses.Front Vet Sci2022https://conductscience.org/library/papers/35711802PubMed
33,571,431Structural insights into the human D1 and D2 dopamine receptor signaling complexes.Cell2021https://conductscience.org/library/papers/33571431PubMed
32,476,098Botanical Therapeutics for Parkinson's Disease.Chin J Integr Med2020https://conductscience.org/library/papers/32476098PubMed
7,264,627Treatment of Parkinson's disease: problems with a progressing disease.J Neural Transm1981https://conductscience.org/library/papers/7264627PubMed
7,026,735The effect of bromocriptine (BCT) on the on-off phenomenon.J Neural Transm1981https://conductscience.org/library/papers/7026735PubMed
6,801,913Increase in noradrenaline-synthesizing enzyme activity in medulla oblongata in Parkinson's disease.Acta Neuropathol1982https://conductscience.org/library/papers/6801913PubMed
6,192,438A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6192438PubMed
3,100,965Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study.Naunyn Schmiedebergs Arch Pharmacol1986https://conductscience.org/library/papers/3100965PubMed
3,063,495Therapeutic applications of bromocriptine in endocrine and neurological diseases.Drugs1988https://conductscience.org/library/papers/3063495PubMed
2,651,567Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group.J Neurol Neurosurg Psychiatry1989https://conductscience.org/library/papers/2651567PubMed
2,647,907The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.J Neurol Neurosurg Psychiatry1989https://conductscience.org/library/papers/2647907PubMed
720,482Antiparkinsonian drug doses and neuroleptic receptors.Experientia1978https://conductscience.org/library/papers/720482PubMed
591,982Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.J Neurol Neurosurg Psychiatry1977https://conductscience.org/library/papers/591982PubMed
501,350Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading.J Neural Transm1979https://conductscience.org/library/papers/501350PubMed
490,153EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.J Neural Transm1979https://conductscience.org/library/papers/490153PubMed

See all 26 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GH12,688PubTator's text mininghttps://conductscience.org/library/genes/2688

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/772175

GET https://conductscience.org/api/papers/v1/772175/cited_by?page=2